PeptideDeck
HomePeptidesKisspeptin-10
Hormonal
Half-life: ~28 minutes (relatively short)
Last updated: July 22, 2026

Kisspeptin-10

Kisspeptin-10 (Metastin 45-54)

Recommended

Purchase Kisspeptin-10

Buy Kisspeptin-10 — 50% Off
Kisspeptin-10 is a truncated form of the kisspeptin peptide that plays a central role in regulating the reproductive hormone axis. Discovered relatively recently (the KISS1 gene was identified in 1996), kisspeptin was found to be essential for puberty initiation and fertility. It works at the top of the hormonal cascade, stimulating GnRH (gonadotropin-releasing hormone) neurons in the hypothalamus, which then trigger LH and FSH release from the pituitary, ultimately increasing testosterone or estrogen production. This 'master switch' role makes kisspeptin-10 interesting for fertility treatments, testosterone optimization, and as a potential alternative to hCG in post-cycle therapy. Unlike direct testosterone or hCG, kisspeptin works through your body's natural regulatory systems from the top down.
Recommended Supplier

Get Kisspeptin-10

Sourced from Ascension Peptides. Verified ≥≥99% purity, third-party tested. COA included.

Buy Kisspeptin-10 — 50% Off
50%

Off with code

PEPTIDEDECK

Table of Contents

What is Kisspeptin-10?

Kisspeptin-10 is a peptide fragment that acts as a master switch for the reproductive hormone system. Discovered in the mid-1990s, kisspeptins were found to be essential for puberty and fertility—without kisspeptin signaling, puberty doesn't occur and reproduction fails.

The kisspeptin system sits at the top of the hormonal cascade. When kisspeptin activates neurons in the hypothalamus, it triggers GnRH (gonadotropin-releasing hormone) release. GnRH then stimulates the pituitary to release LH and FSH, which in turn stimulate the gonads to produce testosterone (in men) or estrogen and progesterone (in women).

Why Kisspeptin-10?

The full kisspeptin peptide has 54 amino acids, but research found that the C-terminal 10 amino acids (kisspeptin-10) retain full biological activity. This smaller fragment is easier to synthesize and study, making it the standard for research and potential therapeutic use.

Applications

Kisspeptin is being actively studied for fertility treatments (IVF, hypothalamic amenorrhea), testosterone optimization, and potentially as an alternative approach to post-cycle therapy. Its mechanism—working through natural systems rather than introducing external hormones—makes it conceptually attractive for those seeking physiological hormone support.

Research Benefits

Stimulates natural LH and FSH release

Increases endogenous testosterone production

Potential fertility enhancement for both sexes

Works through physiological pathways (GnRH system)

May support natural hormone optimization

Alternative PCT approach to hCG

Rapid but transient effects (controllable)

Extensively researched in reproductive medicine

How Kisspeptin-10 Works

Kisspeptin works at the apex of the hypothalamic-pituitary-gonadal (HPG) axis, the hormonal system controlling reproduction.

The Cascade

Kisspeptin-10 binds to KISS1R receptors on GnRH neurons in the hypothalamus. This stimulation causes GnRH neurons to release GnRH in pulses. GnRH travels through portal blood vessels to the pituitary gland. The pituitary responds by releasing LH (luteinizing hormone) and FSH (follicle-stimulating hormone). In men, LH stimulates testicular Leydig cells to produce testosterone. In women, LH and FSH regulate ovarian function, estrogen production, and ovulation.

Why This Matters

Working at the top of the cascade means kisspeptin stimulates the entire natural system rather than bypassing it. The testosterone or estrogen produced is entirely endogenous—made by your own gonads in response to your own LH. Feedback systems remain operational. This contrasts with direct hormone administration or even hCG, which acts lower in the cascade.

Short Half-Life

Kisspeptin-10 has a half-life of only about 28 minutes. Effects are transient—a single dose produces a short pulse of LH release that returns to baseline within hours. This is both a limitation (requiring frequent dosing for sustained effects) and potentially an advantage (effects don't accumulate, mimics natural pulsatility).

Research Applications

Fertility and reproductive medicine

Active research area with published studies

Testosterone optimization

Active research area with published studies

Hypogonadism treatment

Active research area with published studies

Post-cycle therapy (PCT)

Active research area with published studies

Puberty disorders

Active research area with published studies

Polycystic ovary syndrome (PCOS)

Active research area with published studies

IVF protocols

Active research area with published studies

Hypothalamic amenorrhea

Active research area with published studies

Research Findings

Kisspeptin research has accelerated rapidly since its discovery, particularly in reproductive medicine.

Male Studies

Research published in the Journal of Clinical Endocrinology & Metabolism demonstrated that kisspeptin-10 administration to healthy men produced rapid, dose-dependent LH release, with consequent testosterone elevation. The response confirms kisspeptin's role as a physiological activator of the reproductive axis.

Fertility Applications

Studies in IVF contexts show kisspeptin can trigger ovulation with reduced risk of ovarian hyperstimulation syndrome compared to hCG—a significant potential advantage. Research in Fertility and Sterility documented successful use in IVF protocols.

Hypothalamic Amenorrhea

Clinical trials in women with hypothalamic amenorrhea (loss of menstruation due to hypothalamic suppression) showed kisspeptin could restore LH pulsatility and potentially ovarian function. Published in the Journal of Clinical Investigation, this research demonstrates kisspeptin's therapeutic potential for functional hypothalamic disorders.

PureBac 7x tested bacteriostatic water 10mL vial
7x Quality Tested Bac Water

Don't ruin a $300 peptide on generic bac water.

Sterile, non-pyrogenic, exactly 0.9% benzyl alcohol, with a COA on every batch. Made for peptide reconstitution, not repackaged from generic stock.

0.9% benzyl alcohol 7x tested in USA COA every batch
Get PureBac bac water From $7.99 · Free shipping over $150

Dosage & Administration

Kisspeptin-10 dosing is not standardized for non-clinical use. The following reflects research protocols and community practices.

Research Doses

Clinical studies have used doses ranging from 1-10mcg/kg for acute stimulation testing, typically IV or subcutaneous.

Optimization/PCT Approaches

Common discussed doses: 100-500mcg subcutaneously, 1-3 times daily. The short half-life necessitates frequent dosing for sustained effects. Some prefer pre-bed dosing to support nocturnal hormonal patterns.

Practical Considerations

Subcutaneous injection is standard. The short duration of action means effects are transient—suitable for pulsatile stimulation but requiring commitment for sustained protocols.

Work out your Kisspeptin-10 draw in units

Enter the vial size, the bacteriostatic water you add and the dose you want, and the calculator gives the syringe units, how long the vial lasts and when to discard it.

Open the peptide calculator

Safety & Side Effects

Kisspeptin-10 shows a favorable safety profile in clinical research.

Common Effects

Flushing and warmth (common with hormonal peptides), injection site reactions, and transient symptoms related to hormone fluctuations.

Notable Safety

No serious adverse effects documented in clinical trials. The short half-life prevents accumulation. Working through natural systems may provide inherent safety compared to exogenous hormones.

Limited Data

Most studies are short-term. Long-term safety of repeated kisspeptin administration isn't fully characterized.

Frequently Asked Questions

How does kisspeptin-10 increase testosterone?
Kisspeptin works at the very top of the hormonal cascade—the hypothalamus. Here's the sequence: Kisspeptin-10 stimulates GnRH neurons in the hypothalamus → GnRH is released and travels to the pituitary → GnRH stimulates LH (and FSH) release from the pituitary → LH travels to the testes and stimulates testosterone production. This is your body's natural pathway for testosterone production. Kisspeptin essentially 'turns up the volume' on this system at its origin point. The advantage is that you're working with physiological systems rather than introducing external hormones. The testosterone you produce is entirely endogenous—made by your own testes in response to your own LH.
Can kisspeptin-10 be used for post-cycle therapy (PCT)?
This is an emerging application with theoretical advantages. After anabolic steroid use, the hypothalamic-pituitary-testicular axis is suppressed. Traditional PCT uses hCG (which mimics LH) and SERMs (which block estrogen feedback). Kisspeptin could work at a higher level—stimulating the hypothalamus to restart natural GnRH pulsation, which then restores the entire cascade naturally. Potential advantages: more physiological recovery, avoids LH receptor desensitization from high-dose hCG. Limitations: short half-life requires frequent dosing, and the system may not respond well if deeply suppressed. Research is limited but the mechanism is sound. Some use kisspeptin alongside traditional PCT rather than as a replacement.
How is kisspeptin-10 different from hCG?
They work at different levels of the hormone axis. hCG: mimics LH directly, acting on the testes to produce testosterone. Bypasses the hypothalamus and pituitary entirely. Can desensitize LH receptors with prolonged high-dose use. Long half-life. Kisspeptin-10: stimulates the hypothalamus to release GnRH, which stimulates LH release naturally. Works through the full cascade. Won't cause LH receptor desensitization (the LH is your own, at physiological pulses). Short half-life means effects don't accumulate. For acute testosterone boosting, hCG is more direct and predictable. For physiological axis support and recovery, kisspeptin is more elegant but less proven.
Does kisspeptin-10 work for both men and women?
Yes—kisspeptin regulates reproduction in both sexes, though effects differ. In men: increases LH, FSH, and testosterone. Potential for fertility enhancement and hormone optimization. In women: increases LH and FSH, potentially triggering ovulation. Being studied for fertility treatments, IVF protocols, and hypothalamic amenorrhea (when periods stop due to hypothalamic dysfunction). The kisspeptin system is actually essential for puberty in both sexes—mutations preventing kisspeptin signaling cause failure to enter puberty. This fundamental role means kisspeptin is relevant to reproductive function regardless of sex.
What's the typical kisspeptin-10 dosing?
Research doses vary widely, and no standardized protocol exists for non-clinical use. Clinical studies have used: Bolus IV: 1-10mcg/kg for acute LH stimulation testing. Subcutaneous: similar doses for fertility protocols. For optimization/PCT applications (non-clinical), commonly discussed ranges are 100-500mcg subcutaneously, 1-3 times daily. The short half-life (~28 minutes) means effects are transient—frequent dosing is needed for sustained effects. Some protocols use it twice daily; others focus on a single pre-bed dose to support nocturnal hormonal patterns. This is not FDA-approved dosing—it's extrapolation from research.
Why isn't kisspeptin used more widely in medicine?
Several practical challenges: Short half-life: the natural peptide clears quickly, requiring frequent dosing or continuous infusion for sustained effects. This is inconvenient for clinical use. Development stage: kisspeptin analogs with longer half-lives are in development but not yet approved. Research focus: most clinical research is in specialized fertility contexts (IVF, hypothalamic amenorrhea), not general hormone optimization. That said, kisspeptin is being actively studied for clinical applications. Longer-acting analogs and different delivery methods may eventually bring it into mainstream medicine. The science strongly supports its utility—the practical challenges are being addressed.
Can kisspeptin help with fertility?
This is its most clinically validated application. Research shows kisspeptin can: trigger ovulation in women, potentially replacing hCG in IVF protocols with fewer side effects (like ovarian hyperstimulation syndrome); treat hypothalamic amenorrhea (restore periods in women whose hypothalamic function is suppressed); and improve sperm parameters in men with certain types of infertility. Clinical trials have demonstrated kisspeptin's efficacy in these contexts. It's not yet standard of care but represents a promising approach, particularly because it works with natural systems rather than overwhelming them with exogenous hormones.
What are the side effects of kisspeptin-10?
Kisspeptin-10 appears well-tolerated in clinical studies. Reported effects are generally mild: flushing and warmth (common with peptides affecting hormones), injection site reactions, and transient symptoms related to hormone fluctuations. No serious adverse effects have been documented in clinical research. The short half-life means effects don't accumulate, which may contribute to the favorable safety profile—you're not maintaining chronically elevated hormone levels. Long-term safety data is limited since most studies are short-term fertility protocols.
Does kisspeptin work if the hypothalamus or pituitary is damaged?
It depends on where the damage is. Kisspeptin works by stimulating GnRH neurons in the hypothalamus. If those neurons are functional, kisspeptin can activate them. If the problem is downstream (pituitary damage), kisspeptin may have limited effect because even if GnRH is released, the pituitary can't respond properly. Clinical studies in hypothalamic amenorrhea (where hypothalamic function is suppressed but not destroyed) show kisspeptin can restore function. In cases of structural damage, other interventions may be needed. Kisspeptin is most useful when the system is functional but underactive—not when key components are destroyed.
How does kisspeptin-10 compare to Clomid or Enclomiphene?
Different mechanisms, same end goal. Clomid/Enclomiphene: block estrogen receptors in the hypothalamus and pituitary. This removes negative feedback, causing increased GnRH and LH release. Works by blocking a signal, not by adding one. Can have estrogenic side effects. Oral administration. Long half-life. Kisspeptin: directly stimulates the system to produce more GnRH. Works by adding a stimulatory signal. No estrogenic effects. Injectable. Short half-life. Both increase testosterone by increasing LH. Clomid/Enclomiphene are more practical (oral, long-acting). Kisspeptin is more physiologically elegant but less convenient. For PCT or testosterone optimization, SERMs remain more practical; kisspeptin is more experimental.

Scientific References

1

Kisspeptin and the regulation of reproduction

Annual Review of Physiology (2010)

2

Kisspeptin-10 stimulates LH release in healthy men

Journal of Clinical Endocrinology & Metabolism (2005)

3

Kisspeptin as a fertility treatment: clinical applications

Neuroendocrinology (2018)

4

Kisspeptin for IVF: reducing ovarian hyperstimulation

Fertility and Sterility (2014)

5

Kisspeptin administration to women with hypothalamic amenorrhea

Journal of Clinical Investigation (2015)

Quick Reference

Molecular Weight1,302.41 Da
Half-Life~28 minutes (relatively short)
Purity≥99%
FormLyophilized powder
SupplierAscension Peptides

Sequence

Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂

Storage

Lyophilized: -20°C | Reconstituted: 2-8°C, use within 2-3 weeks

Related Peptides

Gonadorelin
Hormonal / PCT
HCG Mechanism and Half-Life
Hormonal